Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells.
about
Understanding natural herpes simplex virus immunity to inform next-generation vaccine designFunctional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell ResponsesThe role of dendritic cells in immunity against primary herpes simplex virus infectionsRecent advances in vaccine development for herpes simplex virus types I and IICell death in the maintenance and abrogation of tolerance: the five Ws of dying cellsA macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacyHIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts.Herpes simplex virus type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences.Inhibition of dendritic cell maturation by group A StreptococcusImmunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newbornHSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target.Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture.A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesisImmunogenicity of cytopathic and noncytopathic viral vectorsSkin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.Antiviral-activated dendritic cells: a paracrine-induced response stateEntry of herpes simplex virus 1 and other alphaherpesviruses via the paired immunoglobulin-like type 2 receptor alpha.Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection.Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon.CD11c controls herpes simplex virus 1 responses to limit virus replication during primary infection.Evasion of early antiviral responses by herpes simplex viruses.Relay of herpes simplex virus between Langerhans cells and dermal dendritic cells in human skin.Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells.Activation of NF-κB in CD8+ dendritic cells Ex Vivo by the γ134.5 null mutant correlates with immunity against herpes simplex virus 1.The Role of Plasmacytoid Dendritic Cells in Innate and Adaptive Immune Responses against Alpha Herpes Virus InfectionsCross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.Apoptosis and antigen receptor function in T and B cells following exposure to herpes simplex virusCervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion.Immunomodulatory effects of HSV-2 infection on immature macaque dendritic cells modify innate and adaptive responsesEfficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model.B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient micePathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation.Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergyDisruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes.The evolving function of Langerhans cells in adaptive skin immunity.Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivectorCurrent concepts of HIV transmission.The cross-priming pathway: a portrait of an intricate immune system.Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells.Lentivirus as a potent and mechanistically distinct vector for genetic immunization
P2860
Q26741484-7E7D7D63-E607-48ED-8426-83C52CFE72D5Q26777948-3EC04CE6-86B4-4F5A-835B-111110B96978Q26827217-7415072D-A25C-4A13-97E4-C9E7255977C4Q26859623-BC5705FD-402C-40A3-84C2-73E49420A34BQ26999223-3ECCDB62-7E1C-4145-8711-00319DC3B713Q27335068-6A8D2D4D-F096-4C02-AC32-7726E4AE92BFQ33303686-E15E8F66-4234-408E-B6F6-423DF5943415Q33558390-BE22F7B8-7F0A-48DC-B0B5-957B3E56B0E7Q33755074-9C1F00D3-C6C8-4670-8D36-80D613C87466Q33835386-071B0D5A-9790-4F33-9842-86BE753AB12BQ33954386-383F1186-13C8-463C-86D1-5426EC8CCA57Q33983315-15105BB4-199C-453C-99A2-23CFC944486AQ34178357-AC76FBFC-42BE-46C2-B99F-E14958C64342Q34716855-BFACF649-8F1B-4D1B-9CDE-E5A1F29697AAQ34801021-EAD2D7FA-13B4-4068-AD1D-BF310E158FD9Q34871428-54BB0267-0638-43CB-ABD8-944583B8DA36Q34952284-4880A95A-8578-468A-A441-AAEB0FE61975Q35056662-EA67624C-958A-488B-A848-166F1E438CF7Q35077019-A24B6D36-F93F-4201-A919-0AFC9DD704BCQ35382523-84A22524-F357-4DC0-A564-3E4FE87DECD4Q35414669-37912AE2-5303-4A3F-A1CB-1DEDE2F72ABEQ35602225-FE6E7A85-12E0-46F6-B75A-09A26F70FA3BQ35648476-CDB1EA42-6ADB-4C3F-8E05-4CB16F0AB196Q35665813-DD433E3C-7B4A-493B-AE87-5C62CF6C4E87Q35692343-8D2299AF-C077-4859-A0CC-E51A47D2500DQ35699002-5F9E5A88-F7DE-4ABF-9B96-C152D6BEF907Q35792771-3D46F189-3D14-4FAD-BA52-9982010D9A75Q35798899-99A8860B-9747-4056-A95C-D56BC6DA95C5Q35847995-370FD861-3952-4DA2-8998-90DC04E12098Q36171970-540202A5-ABF5-481E-B4D0-C95B86677583Q36315467-61899EA3-EEAD-4991-A0B6-652B1A5AE3EAQ36506900-8A2C52A3-0C10-49EF-B56F-668167093CA0Q36559887-91CDECC6-EE2C-4F8E-BFF1-DBF555B52FFFQ36570266-26FCF991-B60A-4B8C-AF21-6C8064FDCAE5Q36627481-CC5892B1-2C92-4DFD-9ABB-81449DBEC02DQ36751598-53C11BCD-BC3A-4536-AE7A-975AD3A9D64DQ36752241-963F84A7-86CF-4819-A17B-5F73A60DB3A3Q36770431-4D9DDCFE-4179-4D23-82EE-082497CE2981Q36878921-70FF9ECA-10A2-47C7-9991-2B37D65CA7FBQ36969195-74107E6E-A74C-4F81-B87C-F8949A2EB645
P2860
Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Herpes simplex virus infection ...... ia uninfected dendritic cells.
@en
Herpes simplex virus infection ...... ia uninfected dendritic cells.
@nl
type
label
Herpes simplex virus infection ...... ia uninfected dendritic cells.
@en
Herpes simplex virus infection ...... ia uninfected dendritic cells.
@nl
prefLabel
Herpes simplex virus infection ...... ia uninfected dendritic cells.
@en
Herpes simplex virus infection ...... ia uninfected dendritic cells.
@nl
P2093
P1476
Herpes simplex virus infection ...... ia uninfected dendritic cells.
@en
P2093
Anthony L Cunningham
Cheryl A Jones
Lidija Bosnjak
Monica Miranda-Saksena
Ross A Boadle
P304
P356
10.4049/JIMMUNOL.174.4.2220
P407
P577
2005-02-01T00:00:00Z